Showing results (1-10 of 715) with videos related to
Sort By:
Pageof 72
Ebiomedicine|June 1, 2022
Predictive value of CD8+ T cell and CD4/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS eventsSergio Serrano-Villar, Kunling Wu, Peter W Hunt, et al.Microbiome|June 21, 2024
From dysbiosis to defense: harnessing the gut microbiome in HIV/SIV therapyJason M Brenchley, Sergio Serrano-VillarFrontiers in Immunology|February 9, 2023
The microbiota as a modulator of mucosal inflammation and HIV/HPV pathogenesis: From association to causationElena Moreno, Raquel Ron, Sergio Serrano-VillarCurrent Opinion in HIV and AIDS|October 17, 2017
The functional consequences of the microbiome in HIV: insights from metabolomic studiesSergio Serrano-Villar, Santiago Moreno, Manuel FerrerTopics in HIV Medicine : a Publication of the International AIDS Society, USA|November 6, 2009
Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapySteven G DeeksAnnual Review of Medicine|November 25, 2010
HIV infection, inflammation, immunosenescence, and agingSteven G DeeksLancet (London, England)|December 20, 2003
Treatment of antiretroviral-drug-resistant HIV-1 infectionSteven G DeeksFrontiers in Immunology|July 19, 2019
HIV, Cancer, and the Microbiota: Common Pathways Influencing Different DiseasesSabina Herrera, Javier Martínez-Sanz, Sergio Serrano-VillarEnfermedades Infecciosas Y Microbiologia Clinica|February 2, 2010
[Etravirine drug interactions]Vicente Estrada Pérez, Clara Sánchez-Parra, Sergio Serrano VillarThe Journal of Antimicrobial Chemotherapy|September 23, 2016
Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patientsSergio Serrano-Villar, Yan Zhou, Anthony J Rodgers, et al.Pageof 72